Z16.341 Resistance to single antimycobacterial drug

Name of the Condition

• Resistance to single antimycobacterial drug (ICD-10-CM Code: Z16.341)

Summary

Resistance to single antimycobacterial drug is a condition where mycobacteria develop the ability to withstand the effects of a specific antimycobacterial agent, reducing the effectiveness of standard treatments. This resistance can limit treatment options for mycobacterial infections, as affected organisms may no longer respond to the targeted drug.

Causes

The primary cause is genetic changes in mycobacteria that reduce antimycobacterial drug effectiveness. These changes may include altered drug targets, increased drug efflux, or enzymatic inactivation of the drug. Resistance can develop due to selective pressure from antimycobacterial use or horizontal gene transfer between mycobacteria.

Risk Factors

• Previous or prolonged use of the specific antimycobacterial drug.
• Inadequate dosing or incomplete treatment courses.
• Exposure to environments with high mycobacterial resistance rates.
• Co-infection with multiple mycobacterial strains.
• Use of substandard or counterfeit antimycobacterial medications.

Symptoms

Resistance itself does not cause symptoms, but infections with resistant mycobacteria may present with persistent or worsening signs of mycobacterial disease, such as fever, cough, weight loss, or organ-specific symptoms, depending on the infection site.

Diagnosis

Diagnosis involves laboratory testing to identify antimycobacterial drug resistance, typically through culture-based susceptibility testing or molecular methods. Results confirm resistance to the specific drug and guide treatment adjustments.

Treatment Options

Treatment focuses on switching to alternative antimycobacterial agents effective against the resistant strain. Regimens may include combination therapy with drugs from different classes to prevent further resistance. Consultation with infectious disease specialists is often recommended.

Prognosis and Follow-Up

Prognosis depends on the extent of resistance, underlying health, and timely treatment adjustment. Regular monitoring of infection status and drug susceptibility is essential to ensure treatment efficacy and prevent complications.

Complications

Complications may include treatment failure, prolonged infection, increased risk of transmission, and the need for more intensive or toxic therapies. Resistance can also limit future treatment options.

Lifestyle & Prevention

Preventive measures include adherence to prescribed treatment courses, avoiding unnecessary antimycobacterial use, and practicing good hygiene to reduce infection risk. In healthcare settings, infection control protocols help minimize transmission.

When to Seek Professional Help

Seek medical attention if infection symptoms persist or worsen despite treatment, or if new symptoms develop. Prompt evaluation is critical to address potential resistance and adjust therapy.

Tips for Medical Coders

Document the specific antimycobacterial drug to which resistance is identified. Ensure clinical documentation supports the resistance diagnosis and any related treatment modifications. Code Z16.341 is used when resistance to a single antimycobacterial drug is confirmed.